PUBLICATIONS
Subscribe to our content
Do you want to keep up to date with the latest legislative developments and publications produced by our Academic Council, as well as all our events?
You can do it by registering here.
Featured publications
PUBLICATION
Administrative liability of the members of a listed company’s audit committee for serious errors or inaccuracies in the audited annual accounts
The Supreme Court’s judgment of 8 October 2020 confirms the administrative liability of Audit Committee members for the inaccuracy or lack of veracity of consolidated annual accounts that have been externally audited
PUBLICATION
Amendment of the legal regime of the organisation and operation of the National Electricity System (Portugal)
The public consultation regarding the long-awaited draft Decree-Law that revokes the legal regulations applicable to the activities of generation, transmission, distribution and supply of electricity and the organisation of electricity markets (the “Draft Decree-law”) is underway, and contributions may be submitted until 24 November 2021 through the Consultation – National Electricity System platform (consultalex.gov.pt).
Go back to 
Filter by… 
Jurisdiction of national courts of States party to the Agreement on a Unified Patent Court in respect of actions relating to classic European patents during the transitional period
During the transitional period of the Agreement on a Unified Patent Court, national courts retain jurisdiction to hear cases concerning classic European patents, without the need for the proprietor to have exercised the opt-out option, i.e. without the need to have excluded the jurisdiction of the Unified Patent Court over such patents. However, the Venice Court ruling discussed here considers that national courts may only be used if the opt-out has been exercised, contradicting the provisions of Article 83 of the Agreement.
¡NEW! 
Ángel García Vidal, Rais Amils
Incompatibility between practising a healthcare profession and having a pecuniary interest in the manufacture or sale of medicinal products or medical devices
Royal Legislative Decree 1/2015, of 24 July, approving the recast version of the Medicinal Products and Medical Devices (Guarantees and Rational Use) Act, prohibits healthcare professionals with prescribing powers from having a direct pecuniary interest in activities related to medicines. This prohibition does not extend to indirect interests, as distinguished in Article 4 of said legislative decree. Judgment no. 483/2025 of the High Court of Justice of the Basque Country concludes that mere membership of a group of companies does not entail incompatibility if each entity retains real autonomy.
6 days ago
Ángel García Vidal
Sustainable Mobility Act 9/2025: measures to promote climate neutrality in the transport sector
This paper presents changes introduced by Act 9/2025 to promote decarbonisation in transport, including obligation for transport entities to calculate and report their carbon footprint, the drawing up of sustainable mobility plans in large centres of activity and companies, measures to electrify ports and promote renewable fuels, the deployment of charging points and the publishing of a national grid capacity map.
6 days ago
Blanca Lozano, Helena Villena
Financial institutions’ customer services following Act 10/2025
Act 10/2025 reforms the regime governing financial institutions’ customer services and introduces a procedure for the submission, processing and resolution of complaints filed by their customers, including special provisions when such customers are consumers, such as a free helpline and the availability of channels that allow for personalised service to vulnerable consumers or people without access to certain basic financial services that are not defined in the new law.
15 Jan, 2026
Reyes Palá
Excessive extension of the Bolar clause in the ‘pharmaceutical legislative package’
The Bolar clause allows studies and trials necessary to obtain marketing authorisations for medicinal products to be carried out without infringing patents. Its scope has grown during the passage of the pharmaceutical legislative package, incorporating more actors and more activities, to include participation in public tenders before the patent expires. This extension raises questions about compatibility with the TRIPS Agreement, which only allows limited exceptions to patent rights. Participation in tenders could be considered an offer to sell, thus violating the limits set by that agreement.
15 Jan, 2026
Ángel García Vidal, Rais Amils
Continuing or permanent building damage and risk of no limitation period (Supreme Court (Civil Division) Judgment no. 1463/2025 of 21 October 2025)
With regard to actions under the Building (Unified Regulation) Act, the Supreme Court reaffirms that there is no continuing damage, but rather permanent damage. The solution is more efficient for all parties, as well as fairer. Also cheaper for the judicial system.
09 Jan, 2026
Ángel Carrasco
Meet ours
Counsels
Academic Counsel
Academic Counsel
Academic Counsel
Academic Counsel
Academic Counsel
Academic Counsel